What is included with this book?
Foreword | p. ix |
Acknowledgments | p. xiii |
About the Author | p. xiv |
To the Reader | p. xv |
Introduction | p. xvii |
Buy Panic | p. 1 |
Uncontrolled Fear | p. 3 |
Expect the Unexpected | p. 5 |
Buying Stocks in Trouble | p. 10 |
Distress Investing | p. 14 |
Concentrate. Diversify Not | p. 21 |
Cruise-Control Strategy | p. 22 |
Basic Research Is Vital | p. 23 |
When Should You Sell? | p. 26 |
Rewards of Concentration | p. 28 |
Best Buy: Is It Ever! | p. 30 |
Don't Catch "Falling Knives" | p. 33 |
U.S. Steel: Definitely a Big Steal | p. 34 |
New Century Financial-an Early Catch | p. 35 |
AMR: Up High in the Sky | p. 37 |
Northwest Airlines: Still Northbound | p. 40 |
Buy the Losers | p. 43 |
Winners Disguised as Losers | p. 45 |
Watch the High-Profile Stocks | p. 47 |
Homebuilders: Ripe for the Picking | p. 50 |
The Price Earnings Ratio Puzzle | p. 54 |
RIMM: A Stock in Motion | p. 57 |
Time Warner: The Giant Has Awakened | p. 61 |
Merck: A Prescription for Winning | p. 68 |
Other Fallen Angels Ready to Fly | p. 73 |
Ford: Not Destined for the Scrapyard | p. 74 |
GM: Not in No Man's Land Anymore | p. 78 |
Motorola: Will It Recover Its Mojo? | p. 80 |
Forget Timing | p. 85 |
Market-Timing Technicians | p. 87 |
Timing: Underwhelming Results | p. 90 |
Institutional Investors Love Timing | p. 91 |
Retail Stores: Not Necessarily Bargains | p. 92 |
Banks: Banking on Some | p. 93 |
Citigroup | p. 94 |
Bank of America | p. 100 |
The Peter Lynch Principle | p. 101 |
Follow the Insider | p. 103 |
The Insiders' World | p. 104 |
A Case of Insider Trading | p. 106 |
Keep an Eye on Insiders' Pals | p. 109 |
The Warren Buffett Watchers | p. 111 |
Warren Buffett Wannabes | p. 114 |
Pressure from Big Stakeholders | p. 117 |
Wild Oats Markets, Inc. (OATS) | p. 119 |
PriceSmart, Inc. (PSMT) | p. 120 |
Oakley, Inc. (OO) | p. 120 |
CECO Environmental Corp. (CECE) | p. 121 |
Kos Pharmaceuticals (KOSP) | p. 122 |
Ferreting Out Takeover Targets | p. 122 |
Don't Fear the Unknown | p. 125 |
The Far-Flung Markets | p. 126 |
China's Booming Market | p. 128 |
Cutting in on Undervalued Stocks | p. 130 |
Mutual Funds | p. 131 |
Exchange Traded Funds (ETFs) | p. 132 |
American Depositary Receipts (ADRs) | p. 135 |
The Biotechs | p. 138 |
How the Pros Check Out the Biotechs | p. 142 |
Scrutinize the Managers | p. 143 |
Biotech ETFs | p. 144 |
Advanced Neuromodulation Systems (ANSI) | p. 145 |
Cleveland BioLabs (CBLI) | p. 146 |
MedImmune (MEDI) | p. 147 |
Some Unrecognized Attractive Biotechs | p. 148 |
Enzo Biochem (ENZ) | p. 148 |
Rosetta Genomics (ROSG) | p. 150 |
Access Pharmaceuticals, Inc. (ACCP) | p. 153 |
Always Invest for the Long Term: Seven Stocks for the Next Seven Years | p. 157 |
The Innovative Apple | p. 164 |
Boeing-The High-Flying Super Machine | p. 166 |
CVS Caremark Corp: The Number-One Value Drug Store Chain | p. 168 |
Genentech: The Biotech Behemoth | p. 169 |
JPMorgan Chase & Co.: Up on Wall Street and Main Street | p. 171 |
Petroleo Brasileiro S.A.: An All-Around Energy Play | p. 174 |
Pfizer, Inc.: The King of Big Pharma | p. 178 |
Epilogue | p. 187 |
Index | p. 193 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.